Health Care Companies By Enterprise Value

Current Valuation
Current ValuationEfficiencyMarket RiskExp Return
1LLY Eli Lilly and
706.58 B
(0.15)
 1.90 
(0.29)
2UNH UnitedHealth Group Incorporated
599.3 B
 0.04 
 1.71 
 0.07 
3NVO Novo Nordisk AS
469.47 B
(0.23)
 1.81 
(0.41)
4JNJ Johnson Johnson
390.51 B
(0.11)
 0.79 
(0.09)
5ABBV AbbVie Inc
383.89 B
(0.04)
 2.09 
(0.08)
6MRK Merck Company
279.44 B
(0.17)
 1.20 
(0.20)
7AZN AstraZeneca PLC ADR
230.47 B
(0.27)
 1.53 
(0.41)
8NVS Novartis AG ADR
224.89 B
(0.22)
 0.99 
(0.22)
9TMO Thermo Fisher Scientific
224.88 B
(0.21)
 1.23 
(0.25)
10ABT Abbott Laboratories
211.79 B
 0.08 
 1.11 
 0.09 
11PFE Pfizer Inc
202.7 B
(0.10)
 1.44 
(0.15)
12AMGN Amgen Inc
201.9 B
(0.15)
 1.69 
(0.25)
13ISRG Intuitive Surgical
188.85 B
 0.09 
 1.72 
 0.16 
14DHR Danaher
185.77 B
(0.14)
 1.32 
(0.18)
15BMY Bristol Myers Squibb
162.52 B
 0.15 
 2.00 
 0.31 
16SYK Stryker
159.36 B
 0.12 
 1.08 
 0.13 
17CVS CVS Health Corp
147.28 B
 0.05 
 2.60 
 0.12 
18BSX Boston Scientific Corp
140.3 B
 0.17 
 0.99 
 0.17 
19SNY Sanofi ADR
137.79 B
(0.18)
 1.22 
(0.22)
20GILD Gilead Sciences
132.06 B
 0.19 
 1.42 
 0.27 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.